{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:07Z","timestamp":1794357967313,"version":"4.9.0"},"publisher-location":"Dordrecht","reference-count":110,"publisher":"Springer Netherlands","isbn-type":[{"value":"9781402088308","type":"print"},{"value":"9781402088315","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-1-4020-8831-5_9","type":"book-chapter","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T06:33:46Z","timestamp":1219732426000},"page":"241-268","source":"Crossref","is-referenced-by-count":323,"title":["Altered Lipid Metabolism in Brain Injury and Disorders"],"prefix":"10.1007","author":[{"given":"Rao Muralikrishna","family":"Adibhatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","volume":"59","author":"L. Aagaard","year":"2007","unstructured":"Aagaard, L. and Rossi, J. J. RNAi therapeutics: Principles, prospects and challenges. Adv Drug Deliv Rev 59 (2007) 75\u201386.","journal-title":"Adv Drug Deliv Rev"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11064-004-9681-8","volume":"30","author":"R. M. Adibhatla","year":"2005","unstructured":"Adibhatla, R. M. and Hatcher, J. F. Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res 30 (2005) 15\u201323.","journal-title":"Neurochem Res"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.freeradbiomed.2005.08.044","volume":"40","author":"R. M. Adibhatla","year":"2006","unstructured":"Adibhatla, R. M. and Hatcher, J. F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40 (2006) 376\u2013387.","journal-title":"Free Radic Biol Med"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2217\/17460875.2.4.403","volume":"2","author":"R. M. Adibhatla","year":"2007","unstructured":"Adibhatla, R. M. and Hatcher, J. F. Role of lipids in brain injury and diseases. Future Lipidol 2 (2007) 403\u2013422.","journal-title":"Future Lipidol"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2741\/2759","volume":"13","author":"R. M. Adibhatla","year":"2008","unstructured":"Adibhatla, R. M. and Hatcher, J. F. Integration of cytokine biology and lipid metabolism in stroke. Front Biosci 13 (2008) 1250\u20131270.","journal-title":"Front Biosci"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"E314","DOI":"10.1208\/aapsj080236","volume":"8","author":"R. M. Adibhatla","year":"2006a","unstructured":"Adibhatla, R. M., Hatcher, J. F. and Dempsey, R. J. Lipids and lipidomics in brain injury and diseases. AAPS J 8 (2006a) E314\u2013E321.","journal-title":"AAPS J"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1074\/jbc.M512112200","volume":"281","author":"R. M. Adibhatla","year":"2006b","unstructured":"Adibhatla, R. M., Hatcher, J. F., Larsen, E. C., Chen, X., Sun, D. and Tsao, F. CDP-choline significantly restores the phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP-phosphocholine cytidylyltransferase after stroke. J Biol Chem 281 (2006b) 6718\u20136725.","journal-title":"J Biol Chem"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/14660820310011278","volume":"4","author":"J. Agar","year":"2003","unstructured":"Agar, J. and Durham, H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 4 (2003) 232\u2013242.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/jnnp.2005.085167","volume":"77","author":"M. Ariza","year":"2006","unstructured":"Ariza, M., Pueyo, R., Matarin, M. del M., Junque, C., Mataro, M., Clemente, I., Moral, P., Poca, M. A., Garnacho, A. and Sahuquillo, J. Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry 77 (2006) 1191\u20131193.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/09540260600583072","volume":"18","author":"G. E. Berger","year":"2006","unstructured":"Berger, G. E., Smesny, S. and Amminger, G. P. Bioactive lipids in schizophrenia. Int Rev Psychiatry 18 (2006) 85\u201398.","journal-title":"Int Rev Psychiatry"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.10.008","volume":"73","author":"M. Bialer","year":"2007","unstructured":"Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E. and Tomson, T. Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res 73 (2007) 1\u201352.","journal-title":"Epilepsy Res"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1527-3458.2007.00020.x","volume":"13","author":"M. J. Bonifacio","year":"2007","unstructured":"Bonifacio, M. J., Palma, P. N., Almeida, L. and Soares-da-Silva, P. S. Catechol-O-methyltransferase and its inhibitors in Parkinson\u2019s disease. CNS Drug Rev 13 (2007) 352\u2013379.","journal-title":"CNS Drug Rev"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","volume":"48","author":"K. J. Bough","year":"2007","unstructured":"Bough, K. J. and Rho, J. M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007) 43\u201358.","journal-title":"Epilepsia"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1194\/jlr.M400496-JLR200","volume":"46","author":"A. Boullier","year":"2005","unstructured":"Boullier, A., Friedman, P., Harkewicz, R., Hartvigsen, K., Green, S. R., Almazan, F., Dennis, E. A., Steinberg, D., Witztum, J. L. and Quehenberger, O. Phosphocholine as a pattern recognition ligand for CD36. J Lipid Res 46 (2005) 969\u2013976.","journal-title":"J Lipid Res"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nm0105-26","volume":"11","author":"D. L. Bratton","year":"2005","unstructured":"Bratton, D. L. and Henson, P. M. Autoimmunity and apoptosis: Refusing to go quietly. Nat Med 11 (2005) 26\u201327.","journal-title":"Nat Med"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nm0704-675","volume":"10","author":"M. P. Burns","year":"2004","unstructured":"Burns, M. P. and Duff, K. Brain on steroids resists neurodegeneration. Nat Med 10 (2004) 675\u2013676.","journal-title":"Nat Med"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2710.2004.00560.x","volume":"29","author":"J. Caballero","year":"2004","unstructured":"Caballero, J. and Nahata, M. Do statins slow down Alzheimer's disease? A review. J Clin Pharm Ther 29 (2004) 209\u2013213.","journal-title":"J Clin Pharm Ther"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2165\/00023210-200620060-00001","volume":"20","author":"N. G. Carlson","year":"2006","unstructured":"Carlson, N. G. and Rose, J. W. Antioxidants in multiple sclerosis: Do they have a role in therapy? CNS Drugs 20 (2006) 433\u2013441.","journal-title":"CNS Drugs"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1084\/jem.20031763","volume":"200","author":"M.-K. Chang","year":"2004","unstructured":"Chang, M.-K., Binder, C. J., Miller, Y. I., Subbanagounder, G., Silverman, G. J., Berliner, J. A. and Witztum, J. L. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 200 (2004) 1359\u20131370.","journal-title":"J Exp Med"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0306-4522(01)00409-2","volume":"109","author":"J. J. Clifford","year":"2002","unstructured":"Clifford, J. J., Drago, J., Natoli, A. L., Wong, J. Y. F., Kinsella, A., Waddington, J. L. and Vaddadi, K. S. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience 109 (2002) 81\u201388.","journal-title":"Neuroscience"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.freeradbiomed.2005.01.019","volume":"38","author":"P. J. Crack","year":"2005","unstructured":"Crack, P. J. and Taylor, J. M. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38 (2005) 1433\u20131444.","journal-title":"Free Radic Biol Med"},{"key":"9_CR22","unstructured":"Cunningham, T. J., Yao, L., Oetinger, M., Cort, L., Blankenhorn, E. P. and Greensteinm, J. I. Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation (2006) 3 doi: 10.1186\/742-2094-3-26."},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.coph.2006.11.001","volume":"7","author":"A. Degroot","year":"2007","unstructured":"Degroot, A. and Nomikos, G. G. In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission. Curr Opin Pharmacol 7 (2007) 62\u201368.","journal-title":"Curr Opin Pharmacol"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/neu.2005.22.106","volume":"22","author":"M. Djebaili","year":"2005","unstructured":"Djebaili, M., Guo, Q., Pettus, E. H., Hoffman, S. W. and Stein, D. G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 22 (2005) 106\u2013118.","journal-title":"J Neurotrauma"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","volume":"62","author":"R. Dringen","year":"2000","unstructured":"Dringen, R. Metabolism and functions of glutathione in brain. Prog Neurobiol 62 (2000) 649\u2013671.","journal-title":"Prog Neurobiol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R. Ehehalt","year":"2003","unstructured":"Ehehalt, R., Keller, P., Haass, C., Thiele, C. and Simons, K. Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts. J Cell Biol 160 (2003) 113\u2013123.","journal-title":"J Cell Biol"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.nrl.0000215789.70804.b0","volume":"12","author":"M. S. Elkind","year":"2006","unstructured":"Elkind, M. S. Inflammation, atherosclerosis, and stroke. Neurologist 12 (2006) 140\u2013148.","journal-title":"Neurologist"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/00004647-200212000-00001","volume":"22","author":"H. C. A. Emsley","year":"2002","unstructured":"Emsley, H. C. A. and Tyrrell, P. J. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 22 (2002) 1399\u20131419.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/pr.58.3.7","volume":"58","author":"A. A. Farooqui","year":"2006","unstructured":"Farooqui, A. A., Ong, W.-Y. and Horrocks, L. A. Inhibitors of brain phospholipase A2 activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58 (2006) 591\u2013620.","journal-title":"Pharmacol Rev"},{"key":"9_CR30","unstructured":"Feng, L. and Prestwich, G. D. (2006) Functional Lipidomics. p. 329, CRC Press, Taylor & Francis Group, Boca Raton"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nrm1423","volume":"5","author":"A. H. Futerman","year":"2004","unstructured":"Futerman, A. H. and van Meer, G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 5 (2004) 554\u2013565.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M604039200","volume":"281","author":"S. Gao","year":"2006","unstructured":"Gao, S., Zhang, R. L., Greenberg, M. E., Sun, M., Chen, X., Levison, B. S., Salomon, R. G. and Hazen, S. L. Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo. J Biol Chem 281 (2006) 31298\u201331308.","journal-title":"J Biol Chem"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M. Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo, M., Lisnock, J., Bull, H. G., Hawes, B. E., Burnett, D. A., Braun, M. P., Crona, J. H., Davis, H. R., Jr., Dean, D. C., Detmers, P. A., Graziano, M. P., Hughes, M., MacIntyre, D. E., Ogawa, A., O'Neill, K. A., Iyer, S. P. N., Shevell, D. E., Smith, M. M., Tang, Y. S., Makarewicz, A. M., Ujjainwalla, F., Altmann, S. W., Chapman, K. T. and Thornberry, N. A. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102 (2005) 8132\u20138137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","volume":"17","author":"M. Gasior","year":"2006","unstructured":"Gasior, M., Rogawski, M. A. and Hartman, A. L. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol 17 (2006) 431\u2013439.","journal-title":"Behav Pharmacol"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M400253-JLR200","volume":"46","author":"S. A. I. Ghesquiere","year":"2005","unstructured":"Ghesquiere, S. A. I., Gijbels, M. J. J., Anthonsen, M. W., van Gorp, P. J. J., van der Made, I., Johansen, B., Hofker, M. H. and de Winther, M. P. J. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition. J Lipid Res 46 (2005) 201\u2013210.","journal-title":"J Lipid Res"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm1073","volume":"10","author":"L. D. Griffin","year":"2004","unstructured":"Griffin, L. D., Gong, W., Verot, L. and Mellon, S. H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nature Med 10 (2004) 704\u2013711.","journal-title":"Nature Med"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"M. O. W. Grimm","year":"2005","unstructured":"Grimm, M. O. W., Grimm, H. S., Patzold, A. J., Zinser, E. G., Halonen, R., Duering, M., Tschape, J.-A., Strooper, B. D., Muller, U., Shen, J. and Hartmann, T. Regulation of cholesterol and sphingomyelin metabolism by amyloid-\u03b2 and presenilin. Nat Cell Biol 7 (2005) 1118\u20131123.","journal-title":"Nat Cell Biol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1602\/neurorx.1.1.80","volume":"1","author":"E. D. Hall","year":"2004","unstructured":"Hall, E. D. and Springer, J. E. Neuroprotection and acute spinal cord injury: A reappraisal. NeuroRx 1 (2004) 80\u2013100.","journal-title":"NeuroRx"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"G. K. Hansson","year":"2006","unstructured":"Hansson, G. K. and Libby, P. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 6 (2006) 508\u2013519.","journal-title":"Nat Rev Immunol"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1471-4159.2007.04715.x","volume":"103","author":"T. Hartmann","year":"2007","unstructured":"Hartmann, T., Kuchenbecker, J. and Grimm, M. O. W. Alzheimer's disease: The lipid connection. J Neurochem 103 (2007) 159\u2013170.","journal-title":"J Neurochem"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/01.nrl.0000256433.15481.eb","volume":"13","author":"R. A. Hauser","year":"2007","unstructured":"Hauser, R. A. and Zesiewicz, T. A. Advances in the pharmacologic management of early Parkinson disease. Neurologist 13 (2007) 126\u2013132.","journal-title":"Neurologist"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","volume":"24","author":"K. Herrup","year":"2004","unstructured":"Herrup, K., Neve, R., Ackerman, S. L. and Copani, A. Divide and die: Cell cycle events as triggers of nerve cell death. J Neurosci 24 (2004) 9232\u20139239.","journal-title":"J Neurosci"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0167-7306(02)35032-4","volume-title":"Brain Lipids and Disorders in Biological Psychiatry","author":"D. Horrobin","year":"2002","unstructured":"Horrobin, D. (2002). The lipid hypothesis of schizophrenia. In E. R. Skinner (eds.), Brain Lipids and Disorders in Biological Psychiatry, pp. 39\u201352. Amsterdam: Elsevier Science."},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00019052-200412000-00012","volume":"17","author":"K. A. Jellinger","year":"2004","unstructured":"Jellinger, K. A. Head injury and dementia. Curr Opin Neurol 17 (2004) 719\u2013723.","journal-title":"Curr Opin Neurol"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/152308604322899378","volume":"6","author":"A. Kadl","year":"2004","unstructured":"Kadl, A., Bochkov, V. N., Huber, J. and Leitinger, N. Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid Redox Signal 6 (2004) 311\u2013320.","journal-title":"Antioxid Redox Signal"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1460-9568.2002.02099.x","volume":"16","author":"K. K. Karishma","year":"2002","unstructured":"Karishma, K. K. and Herbert, J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16 (2002) 445\u2013453.","journal-title":"Eur J Neurosci"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1050-1738(01)00143-8","volume":"12","author":"P. K. J. Kinnunen","year":"2002","unstructured":"Kinnunen, P. K. J. and Holopainen, J. M. Sphingomyelinase activity of LDL \u2013 A link between atherosclerosis, ceramide, and apoptosis? Trends Cardiovasc Med 12 (2002) 37\u201342.","journal-title":"Trends Cardiovasc Med"},{"key":"9_CR48","first-page":"RA5","volume":"12","author":"P. Kougias","year":"2006","unstructured":"Kougias, P., Chai, H., Lin, P. H., Lumsden, A. B., Yao, Q. and Chen, C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: Mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 12 (2006) RA5\u2013R16.","journal-title":"Med Sci Monit"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0014-5793(02)03407-5","volume":"531","author":"M. Kronke","year":"2002","unstructured":"Kronke, M. and Adam-Klages, S. Role of caspases in TNF-mediated regulation of cPLA2. FEBS Lett 531 (2002) 18\u201322.","journal-title":"FEBS Lett"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1086\/426001","volume":"75","author":"C. B. Kunst","year":"2004","unstructured":"Kunst, C. B. Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet 75 (2004) 933\u2013947.","journal-title":"Am J Hum Genet"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.jcbfm.9600369","volume":"27","author":"A. Kunz","year":"2007","unstructured":"Kunz, A., Anrather, J., Zhou, P., Orio, M. and Iadecola, C. Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J Cereb Blood Flow Metab 27 (2007) 545\u2013551.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9_CR52","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/01.STR.31.8.1953","volume":"31","author":"P. A. Lapchak","year":"2000","unstructured":"Lapchak, P. A., Chapman, D. F., Nunez, S. Y. and Zivin, J. A. Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: Possible involvement of GABAA receptors. Stroke 31 (2000) 1953\u20131956.","journal-title":"Stroke"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/01.nrl.0000256353.14257.7c","volume":"13","author":"S. M. LaRoche","year":"2007","unstructured":"LaRoche, S. M. A new look at the second-generation antiepileptic drugs: A decade of experience. Neurologist 13 (2007) 133\u2013139.","journal-title":"Neurologist"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.neuroscience.2007.02.022","volume":"146","author":"E. C. Larsen","year":"2007","unstructured":"Larsen, E. C., Hatcher, J. F. and Adibhatla, R. M. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells. Neuroscience 146 (2007) 946\u2013961.","journal-title":"Neuroscience"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1161\/CIRCULATIONAHA.106.671420","volume":"115","author":"S. Lavi","year":"2007","unstructured":"Lavi, S., McConnell, J. P., Rihal, C. S., Prasad, A., Mathew, V., Lerman, L. O. and Lerman, A. Local production of lipoprotein-associated phospholipase A2 and lyso-phosphatidylcholine in the coronary circulation: Association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115 (2007) 2715\u20132721.","journal-title":"Circulation"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2005.03.033","volume":"39","author":"K. J. Liu","year":"2005","unstructured":"Liu, K. J. and Rosenberg, G. A. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39 (2005) 71\u201380.","journal-title":"Free Radic Biol Med"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1021\/ac050624t","volume":"77","author":"X. Liu","year":"2005","unstructured":"Liu, X., Lovell, M. A. and Lynn, B. C. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC\/MS\/MS and its application to human brain tissue. Anal Chem 77 (2005) 5982\u20135989.","journal-title":"Anal Chem"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1172\/JCI25420","volume":"115","author":"W. J. Lukiw","year":"2005","unstructured":"Lukiw, W. J., Cui, J.-G., Marcheselli, V. L., Bodker, M., Botkjaer, A., Gotlinger, K., Serhan, C. N. and Bazan, N. G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115 (2005) 2774\u20132783.","journal-title":"J Clin Invest"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.expneurol.2004.11.014","volume":"192","author":"J. R. Lynch","year":"2005","unstructured":"Lynch, J. R., Wang, H., Mace, B., Leinenweber, S., Warner, D. S., Bennett, E. R., Vitek, M. P., McKenna, S. and Laskowitz, D. T. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol 192 (2005) 109\u2013116.","journal-title":"Exp Neurol"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","volume":"81","author":"M. Maccarrone","year":"2007","unstructured":"Maccarrone, M., Battista, N. and Centonze, D. The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases. Prog Neurobiol 81 (2007) 349\u2013379.","journal-title":"Prog Neurobiol"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1227\/01.NEU.0000255346.25959.99","volume":"60","author":"A. Mahmood","year":"2007","unstructured":"Mahmood, A., Lu, D., Qu, C., Goussev, A. and Chopp, M. Treatment of traumatic brain injury with a combination therapy of marrow stromal cells and atorvastatin in rats. Neurosurgery 60 (2007) 546\u2013554.","journal-title":"Neurosurgery"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nm0706-747","volume":"12","author":"A. Mandavilli","year":"2006","unstructured":"Mandavilli, A. The amyloid code. Nat Med 12 (2006) 747\u2013751.","journal-title":"Nat Med"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.freeradbiomed.2005.05.003","volume":"39","author":"I. Margaill","year":"2005","unstructured":"Margaill, I., Plotkine, M. and Lerouet, D. Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39 (2005) 429\u2013443.","journal-title":"Free Radic Biol Med"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","volume":"827","author":"E. Mariani","year":"2005","unstructured":"Mariani, E., Polidori, M. C., Cherubini, A. and Mecocci, P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J Chromatog B 827 (2005) 65\u201375.","journal-title":"J Chromatog B"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1084\/jem.20050665","volume":"202","author":"S. Marusic","year":"2005","unstructured":"Marusic, S., Leach, M. W., Pelker, J. W., Azoitei, M. L., Uozumi, N., Cui, J., Shen, M. W. H., DeClercq, C. M., Miyashiro, J. S., Carito, B. A., Thakker, P., Simmons, D. L., Leonard, J. P., Shimizu, T. and Clark, J. D. Cytosolic phospholipase A2\u03b1-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med 202 (2005) 841\u2013851.","journal-title":"J Exp Med"},{"key":"9_CR66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","volume":"31","author":"C. E. Marx","year":"2006a","unstructured":"Marx, C. E., Stevens, R. D., Shampine, L. J., Uzunova, V., Trost, W. T., Butterfield, M. I., Massing, M. W., Hamer, R. M., Morrow, A. L. and Lieberman, J. A. Neuroactive steroids are altered in schizophrenia and bipolar disorder: Relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31 (2006a) 1249\u20131263.","journal-title":"Neuropsychopharmacology"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.biopsych.2006.06.017","volume":"60","author":"C. E. Marx","year":"2006b","unstructured":"Marx, C. E., Trost, W. T., Shampine, L. J., Stevens, R. D., Hulette, C. M., Steffens, D. C., Ervin, J. F., Butterfield, M. I., Blazer, D. G., Massing, M. W. and Lieberman, J. A. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol Psych 60 (2006b) 1287\u20131294.","journal-title":"Biol Psych"},{"key":"9_CR68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ncb1105-1045","volume":"7","author":"M. P. Mattson","year":"2005","unstructured":"Mattson, M. P., Cutler, R. G. and Jo, D. G. Alzheimer peptides perturb lipid-regulating enzymes. Nat Cell Biol 7 (2005) 1045\u20131047.","journal-title":"Nat Cell Biol"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"F. R. Maxfield","year":"2005","unstructured":"Maxfield, F. R. and Tabas, I. Role of cholesterol and lipid organization in disease. Nature 438 (2005) 612\u2013621.","journal-title":"Nature"},{"key":"9_CR70","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1523\/JNEUROSCI.5376-06.2007","volume":"27","author":"B. W. McColl","year":"2007","unstructured":"McColl, B. W., Rothwell, N. J. and Allan, S. M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 27 (2007) 4403\u20134412.","journal-title":"J Neurosci"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","volume":"54","author":"S. L. Mehta","year":"2007","unstructured":"Mehta, S. L., Manhas, N. and Raghubir, R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54 (2007) 34\u201366.","journal-title":"Brain Res Rev"},{"key":"9_CR72","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L. Minghetti","year":"2004","unstructured":"Minghetti, L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropath Exp Neurol 63 (2004) 901\u2013910.","journal-title":"J Neuropath Exp Neurol"},{"key":"9_CR73","unstructured":"Moses, G. S., Jensen, M. D., Lue, L. F., Walker, D. G., Sun, A. Y., Simonyi, A. and Sun, G. Y. Secretory PLA2-IIA: A new inflammatory factor for Alzheimer's disease. J Neuroinflammation 3 (2006) doi:10.1186\/742-2094-3-28."},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/nen.0b013e31803d3b02","volume":"66","author":"N. A. Muma","year":"2007","unstructured":"Muma, N. A. Transglutaminase is linked to neurodegenerative diseases. J Neuropathol Exp Neurol 66 (2007) 258\u2013263.","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2741\/2220","volume":"12","author":"D. Nicolo","year":"2007","unstructured":"Nicolo, D., Varadhachary, A. S. and Monestier, M. Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies. Front Biosci 12 (2007) 2171\u20132182.","journal-title":"Front Biosci"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/01.wco.0000187248.21103.c5","volume":"18","author":"N. Nirmalananthan","year":"2005","unstructured":"Nirmalananthan, N. and Greensmith, L. Amyotrophic lateral sclerosis: Recent advances and future therapies. Curr Opin Neurol 18 (2005) 712\u2013719.","journal-title":"Curr Opin Neurol"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S. Oddo","year":"2004","unstructured":"Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H. and LaFerla, F. M. A\u03b2 immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43 (2004) 321\u2013332.","journal-title":"Neuron"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","volume":"111","author":"H.-H. S. Oei","year":"2005","unstructured":"Oei, H.-H. S., van der Meer, I. M., Hofman, A., Koudstaal, P. J., Stijnen, T., Breteler, M. M. B. and Witteman, J. C. M. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: The Rotterdam study. Circulation 111 (2005) 570\u2013575.","journal-title":"Circulation"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P. Pacher","year":"2006","unstructured":"Pacher, P., Batkai, S. and Kunos, G. ,The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006) 389\u2013462.","journal-title":"Pharmacol Rev"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1079\/BJN20051591","volume":"95","author":"D. Papandreou","year":"2006","unstructured":"Papandreou, D., Pavlou, E., Kalimeri, E. and Mavromichalis, I. The ketogenic diet in children with epilepsy. Br J Nutr 95 (2006) 5\u201313.","journal-title":"Br J Nutr"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrn2233","volume":"8","author":"D. Piomelli","year":"2007","unstructured":"Piomelli, D., Astarita, G. and Rapaka, R. A neuroscientist's guide to lipidomics. Nat Rev Neurosci 8 (2007) 743\u2013754.","journal-title":"Nat Rev Neurosci"},{"key":"9_CR82","doi-asserted-by":"crossref","unstructured":"Puglielli, L. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? Neurobiol Aging (2007) doi:10.1016\/j.neurobiolaging.2007.01.010.","DOI":"10.1016\/j.neurobiolaging.2007.01.010"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1212\/01.wnl.0000169025.09670.6d","volume":"65","author":"B. K. Puri","year":"2005","unstructured":"Puri, B. K., Leavitt, B. R., Hayden, M. R., Ross, C. A., Rosenblatt, A., Greenamyre, J. T., Hersch, S., Vaddadi, K. S., Sword, A., Horrobin, D. F., Manku, M. and Murck, H. Ethyl-EPA in Huntington disease: A double-blind, randomized, placebo-controlled trial. Neurology 65 (2005) 286\u2013292.","journal-title":"Neurology"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jnr.21206","volume":"85","author":"J. Qin","year":"2007","unstructured":"Qin, J., Goswami, R., Balabanov, R. and Dawson, G. Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J Neurosci Res 85 (2007) 977\u2013984.","journal-title":"J Neurosci Res"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1194\/jlr.D300032-JLR200","volume":"45","author":"P. C. Reid","year":"2004","unstructured":"Reid, P. C., Sakashita, N., Sugii, S., Ohno-Iwashita, Y., Shimada, Y., Hickey, W. F. and Chang, T.-Y. A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain. J Lipid Res 45 (2004) 582\u2013591.","journal-title":"J Lipid Res"},{"key":"9_CR86","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001199-200605000-00010","volume":"21","author":"J. L. Rigg","year":"2006","unstructured":"Rigg, J. L. and Zafonte, R. D. Corticosteroids in TBI: Is the story closed? J Head Trauma Rehab 21 (2006) 285\u2013288.","journal-title":"J Head Trauma Rehab"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ana.20738","volume":"59","author":"P. Samadi","year":"2006","unstructured":"Samadi, P., Gr\u00e9goire, L., Rouillard, C., B\u00e9dard, P. J., Di Paolo, T. and L\u00e9vesque, D. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol 59 (2006) 282\u2013288.","journal-title":"Ann Neurol"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.annemergmed.2005.12.011","volume":"47","author":"I. Sayeed","year":"2006","unstructured":"Sayeed, I., Guo, Q., Hoffman, S. W. and Stein, D. G. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 47 (2006) 381\u2013389.","journal-title":"Ann Emerg Med"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","volume":"30","author":"E. Schuchman","year":"2007","unstructured":"Schuchman, E. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann\u2013Pick disease. J Inher Metabol Dis 30 (2007) 654\u2013663.","journal-title":"J Inher Metabol Dis"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.expneurol.2004.03.016","volume":"188","author":"C. Schwab","year":"2004","unstructured":"Schwab, C., Hosokawa, M. and McGeer, P. L. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 188 (2004) 52\u201364.","journal-title":"Exp Neurol"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"C. N. Serhan","year":"2007","unstructured":"Serhan, C. N. Resolution phases of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Ann Rev Immunol 25 (2007) 101\u2013137.","journal-title":"Ann Rev Immunol"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R. Sharon","year":"2003","unstructured":"Sharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A. and Selkoe, D. J. The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37 (2003) 583\u2013595.","journal-title":"Neuron"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"D. L. Simmons","year":"2004","unstructured":"Simmons, D. L., Botting, R. M. and Hla, T. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56 (2004) 387\u2013437.","journal-title":"Pharmacol Rev"},{"key":"9_CR94","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","volume":"62","author":"E. P. Simpson","year":"2004","unstructured":"Simpson, E. P., Henry, Y. K., Henkel, J. S., Smith, R. G. and Appel, S. H. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology 62 (2004) 1758\u20131765.","journal-title":"Neurology"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/jnnp.2005.074617","volume":"77","author":"C. Smith","year":"2006","unstructured":"Smith, C., Graham, D. I., Murray, L. S., Stewart, J. and Nicoll, J. A. R. Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. J Neurol Neurosurg Psychiatry 77 (2006) 363\u2013366.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9_CR96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","volume":"1762","author":"E. C. Stack","year":"2006","unstructured":"Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M. and Ferrante, R. J. Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice. Biochim Biophys Acta 1762 (2006) 373\u2013380.","journal-title":"Biochim Biophys Acta"},{"key":"9_CR97","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/01.STR.0000226901.34927.10","volume":"37","author":"G. Stoll","year":"2006","unstructured":"Stoll, G. and Bendszus, M. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923\u20131932.","journal-title":"Stroke"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1073\/pnas.0307325101","volume":"101","author":"M. Suzuki","year":"2004","unstructured":"Suzuki, M., Wright, L. S., Marwah, P., Lardy, H. A. and Svendsen, C. N. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci USA 101 (2004) 3202\u20133207.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1172\/JCI30060","volume":"117","author":"R. E. Temel","year":"2007","unstructured":"Temel, R. E., Tang, W., Ma, Y., Rudel, L. L., Willingham, M. C., Ioannou, Y. A., Davies, J. P., Nilsson, L.-M. and Yu, L. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 117 (2007) 1968\u20131978.","journal-title":"J Clin Invest"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","volume":"580","author":"J. E. Vance","year":"2006","unstructured":"Vance, J. E. Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett 580 (2006) 5518\u20135524.","journal-title":"FEBS Lett"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1523\/JNEUROSCI.4520-04.2005","volume":"25","author":"J. M. Wang","year":"2005","unstructured":"Wang, J. M., Johnston, P. B., Ball, B. G. and Brinton, R. D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J Neurosci 25 (2005) 4706\u20134718.","journal-title":"J Neurosci"},{"key":"9_CR102","doi-asserted-by":"crossref","unstructured":"Wang, J. M., Liu, L., Irwin, R. W., Chen, S. and Brinton, R. D. Regenerative potential of allopregnanolone. Brain Res Rev (2007a) In press: doi:10.1016\/j.brainresrev.2007.08.010.","DOI":"10.1016\/j.brainresrev.2007.08.010"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2006.11.014","volume":"184","author":"Q. Wang","year":"2007b","unstructured":"Wang, Q., Tang, X. N. and Yenari, M. A. The inflammatory response in stroke. J Neuroimmunol 184 (2007b) 53\u201368.","journal-title":"J Neuroimmunol"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tins.2003.08.001","volume":"26","author":"K. Welch","year":"2003","unstructured":"Welch, K. and Yuan, J. \u03b1-Synuclein oligomerization: A role for lipids? Trends Neurosci 26 (2003) 517\u2013519.","journal-title":"Trends Neurosci"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1517\/13543784.15.12.1479","volume":"15","author":"J. F. Whitfield","year":"2006","unstructured":"Whitfield, J. F. Can statins put the brakes on Alzheimer's disease? Expert Opin Investig Drugs 15 (2006) 1479\u20131485.","journal-title":"Expert Opin Investig Drugs"},{"key":"9_CR106","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","volume":"27","author":"T. I. Williams","year":"2006","unstructured":"Williams, T. I., Lynn, B. C., Markesbery, W. R. and Lovell, M. A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 27 (2006) 1094\u20131099.","journal-title":"Neurobiol Aging"},{"key":"9_CR107","first-page":"335","volume":"58","author":"K. Wojtal","year":"2006","unstructured":"Wojtal, K., Trojnar, M. K. and Czuczwar, S. J. Endogenous neuroprotective factors: Neurosteroids. Pharmacol Reports 58 (2006) 335\u2013340.","journal-title":"Pharmacol Reports"},{"key":"9_CR108","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jnen\/59.12.1106","volume":"59","author":"C. Xie","year":"2000","unstructured":"Xie, C., Burns, D. K., Turley, S. D. and Dietschy, J. M. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J Neuropathol Exp Neurol 59 (2000) 1106\u20131117.","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR109","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1471-4159.2007.04866.x","volume":"103","author":"A. R. Young","year":"2007","unstructured":"Young, A. R., Ali, C., Duretete, A. and Vivien, D. Neuroprotection and stroke: Time for a compromise. J Neurochem 103 (2007) 1302\u20131309.","journal-title":"J Neurochem"},{"key":"9_CR110","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1373\/clinchem.2006.070672","volume":"52","author":"A. Zalewski","year":"2006","unstructured":"Zalewski, A., Nelson, J. J., Hegg, L. and Macphee, C. Lp-PLA2: A new kid on the block. Clin Chem 52 (2006) 1645\u20131650.","journal-title":"Clin Chem"}],"container-title":["Subcellular Biochemistry","Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4020-8831-5_9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T01:27:26Z","timestamp":1619659646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4020-8831-5_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9781402088308","9781402088315"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/978-1-4020-8831-5_9","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4020-8831-5","asserted-by":"object"}]},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[]}}